Inhibition of Scarb1 on Endothelial Cells Attenuates Pressure Overload-induced Heart Failure Progression

Q: What is the clinical evidence from this study?

Population: Heart failure. Intervention: EC-specific Scarb1 knockout and systemic SCARB1 inhibition. Primary outcome: Heart failure progression.

Q: What type of study is this?

This is a Animal Study study (also classified as: Observational).

Toshiomi Katsuki; Dai Kusumoto; Yohei Akiba; Mai Kimura; Jin Komuro; Takahiro Nakamura; Hisayuki Hashimoto; Thukaa Kouka; Kazuhisa Sugai; Yoshinori Katsumata; Masaki Miyasaka; Yutaka Suzuki; Junko Kuramoto; Yoshiaki Kubota; Keiichi Fukuda; Shinsuke Yuasa; Masaki Ieda

doi:10.1016/j.jacbts.2025.05.003

August 1, 2025JACC Basic to Translational ScienceOpen Access

Inhibition of Scarb1 on Endothelial Cells Attenuates Pressure Overload-induced Heart Failure Progression

View Full Paper

Ask AI

Bookmark

Share

Key result

SCARB1 inhibition attenuates heart failure progression in preclinical models.

Why the study?

Does SCARB1 inhibition attenuate heart failure progression in a mouse model?

Key Points

Inhibiting Scarb1 in endothelial cells attenuates heart failure progression, highlighting its potential as a therapeutic target.
Key findings indicate that Scarb1 knockout in endothelial cells reduces inflammatory and fibrotic gene expression linked to heart failure.
Using single-cell RNA-sequencing and spatial omics, the study shows that Scarb1 mediates important EC-fibroblast interactions during heart failure.
Results suggest that targeting SCARB1 may open new avenues for endothelial cell-focused interventions in managing heart failure.

Structured PICO

Does SCARB1 inhibition attenuate heart failure progression in a mouse model?

P

Population

Mouse heart failure model (pressure overload-induced) and in vitro models

I

Intervention

EC-specific Scarb1 knockout and systemic SCARB1 inhibition

O

Outcome

Heart failure progressionsurrogate

Implication

SCARB1 inhibition attenuates pressure overload-induced heart failure progression in preclinical models, suggesting a novel therapeutic target.

Abstract

Inappropriate endothelial cell (EC) interactions contribute to heart failure; however, their precise mechanisms remain poorly understood. This study investigated EC-fibroblast interactions mediated by Scarb1 using single-cell RNA-sequencing analysis in a mouse heart failure model. ECs exhibited inflammatory and fibrotic gene expression, with Scarb1-mediated fibroblast-EC interactions driving disease progression. EC-specific Scarb1 knockout and systemic SCARB1 inhibition attenuated heart failure progression. In vitro and spatial omics analyses confirmed the role of SCARB1 in ECs and cell-cell interaction during heart failure progression. These findings highlight SCARB1 as a promising therapeutic target for EC-focused interventions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Katsuki et al. (2025) studied Heart failure. EC-specific Scarb1 knockout and systemic SCARB1 inhibition was evaluated on Heart failure progression. EC-specific Scarb1 knockout and systemic SCARB1 inhibition attenuated heart failure progression in a mouse model.

synapsesocial.com/papers/68c19f9154b1d3bfb60dae9d https://doi.org/10.1016/j.jacbts.2025.05.003

View Full Paper

Ask AI

Bookmark

Share

Inhibition of Scarb1 on Endothelial Cells Attenuates Pressure Overload-induced Heart Failure Progression

Key Points

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Inhibition of Scarb1 on Endothelial Cells Attenuates Pressure Overload-induced Heart Failure Progression

Key Points

Structured PICO

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from JACC Basic to Translational Science

Keep reading

More related papers

More from JACC Basic to Translational Science